Asia Horizon is a licensed producer focused on Asia's emerging hemp-derived cannabinoid industry with an initial focus on China, where the company is developing a large-scale EU GMP-certified processing and production facility to provide low-cost cannabinoids for the global pharmaceutical supply chain and the emerging Chinese domestic market. The company is also a distributor of Western-branded cannabinoid consumer products in China. Combining Western industry expertise with Asian efficiencies and attractive marketplace opportunities, we are charting an early course to build significant value in a license-constrained environment. Asia Horizon aims to create positive change advancing the next frontier in the development of the global hemp industry. For more information, please visit https://asiahorizongroup.com/.
